Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Acute Lung Injury to Respiratory Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Acute Lung Injury to Respiratory Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Acute Lung Injury Therapeutics Clinical Trials 27 Prominent Drugs 28 Clinical Trial Profile Snapshots 29 Appendix 93 Abbreviations 93 Definitions 93 Research Methodology 94 Secondary Research 94 About GlobalData 95 Contact Us 95 Disclaimer 95 Source 96

List of Tables Acute Lung Injury Therapeutics, Global, Clinical Trials by Region, 2016* 6 Acute Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Acute Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Acute Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Acute Lung Injury Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Acute Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Acute Lung Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13 Proportion of Acute Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2016* 14 Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Acute Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2016* 17 Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Acute Lung Injury Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Acute Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Acute Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Acute Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Acute Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Acute Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Acute Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Acute Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures Acute Lung Injury Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Acute Lung Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Acute Lung Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Acute Lung Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Acute Lung Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Acute Lung Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Proportion of Acute Lung Injury to Respiratory Clinical Trials, G7 Countries (%), 2016* 14 Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Acute Lung Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Acute Lung Injury to Respiratory Clinical Trials, E7 Countries (%), 2016* 17 Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Acute Lung Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Acute Lung Injury Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Acute Lung Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Acute Lung Injury Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Acute Lung Injury Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Acute Lung Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Acute Lung Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Acute Lung Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Acute Lung Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Acute Lung Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 94

GlaxoSmithKline Plc Pierrel S.p.A. Silence Therapeutics Plc Menemsha Pharmaceuticals Ltd F. Hoffmann-La Roche Ltd. Eli Lilly and Company Asklepion Pharmaceuticals, LLC Altor BioScience Corporation Actelion Ltd Abbott Laboratories